Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Vomiting 1Nausea 1Glioma 1

Interventions

Dexamethasone 33Palonosetron 27Aprepitant 24Ondansetron 23Granisetron 14Calcium Dobesilate 8Therapeutics 7Olanzapine 6fosaprepitant 5dexamethasone acetate 5netupitant, palosentron drug combination 4casopitant 4Doxorubicin 4Cyclophosphamide 4Acupressure 4netupitant 3dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Radiotherapy 3Metoclopramide 3Dronabinol 3Analgesia 3ramosetron 2ginger extract 2dexamethasone 21-phosphate 2Vincristine 2Tablets 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Vomiting × rolapitant × Clear all
NCT02991456 2023-07-11

Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

Duke University

Phase 2 Completed
48 enrolled 25 charts
CNS

Glioma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡